We are live on ! Find out more
GIM

Greylin Investment Management Portfolio holdings

AUM $598M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+7.5%
1 Year Est. Return
+18.59%
3 Year Est. Return
+52.1%
5 Year Est. Return
+133.23%
10 Year Est. Return
+214.42%
AUM
$417M
AUM Growth
+$15.8M
Cap. Flow
-$10.8M
Cap. Flow %
-2.59%
Top 10 Hldgs %
76.49%
Holding
76
New
2
Increased
13
Reduced
41
Closed
8

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$3.71M
2
GSK icon
GSK
GSK
+$1.94M
3
KMI icon
Kinder Morgan
KMI
+$622K
4
PFE icon
Pfizer
PFE
+$402K
5
VIVO
Meridian Bioscience Inc
VIVO
+$348K

Top Sells

Rank Stock Value
1
USB icon
US Bancorp
USB
+$3.68M
2
LNKD
LinkedIn Corporation
LNKD
+$3.09M
3
PSX icon
Phillips 66
PSX
+$1.9M
4
JOY
Joy Global Inc
JOY
+$1.2M
5
BHI
Baker Hughes
BHI
+$1.17M

Sector Composition

Rank Sector Weight
1 Financials 38.77%
2 Energy 17.96%
3 Healthcare 11.17%
4 Technology 9.5%
5 Consumer Discretionary 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LNKD
76
DELISTED
LinkedIn Corporation
LNKD
– –
-16,155
Closed -$3.09M
1 2 3
4

Similar funds

MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
PRC
Pearl River Capital Niles, Michigan $630M AUM 17.08% 1-Year Est. Return
SCM
Sahana Capital Management Greenwich, Connecticut $645M AUM 23.48% 1-Year Est. Return
IFAM
Institutional & Family Asset Management Fort Collins, Colorado $654M AUM 12.29% 1-Year Est. Return
PWS
Private Wealth Strategies New Albany, Ohio $498M AUM 17.23% 1-Year Est. Return
AT
Arden Trust Wilmington, Delaware $716M AUM 17.63% 1-Year Est. Return
JWM
Janiczek Wealth Management Denver, Colorado $477M AUM 15.17% 1-Year Est. Return
TWM
TMD Wealth Management Scottsdale, Arizona $456M AUM 11.92% 1-Year Est. Return

Greylin Investment Management's Q4 2016 Portfolio in Review

As of Q4 2016, Greylin Investment Management held 76 positions worth $417M, up 4% from $401M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Greylin Investment Management's Q4 2016 filing shows 2 new, 13 increased, 41 reduced and 8 closed positions. Its largest new stake was Teva Pharmaceuticals: 92,855 shares worth $3.37M. The largest sale was US Bancorp, an estimated $3.68M.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 36% a quarter earlier, followed by Energy and Healthcare.

  • Greylin Investment Management's largest Q4 2016 buy was Teva Pharmaceuticals: 92,855 shares worth $3.37M.
  • Greylin Investment Management added most to GSK in Q4 2016, an estimated $1.94M increase.
  • Greylin Investment Management's biggest Q4 2016 reduction was US Bancorp, cutting an estimated $3.68M.
  • Greylin Investment Management fully exited LinkedIn Corporation in Q4 2016, selling an estimated $3.09M.
  • Greylin Investment Management's ten largest holdings make up 76% of its $417M portfolio in Q4 2016.
  • Greylin Investment Management opened 2 new positions and closed 8 in Q4 2016.
  • Greylin Investment Management's portfolio value rose 4% quarter-over-quarter to $417M.

Based on Greylin Investment Management's 13F filing for Q4 2016, filed 18 Jan 2017.